IPOPEMA Securities (WAR:IPE) Current Accrued Expense: zł0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:IPE IPOPEMA Securities SA WAR:IPE
56 GF Score
Price zł9.40
GF Value zł3.63
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is IPOPEMA Securities Current Accrued Expense?

IPOPEMA Securities WAR:IPE -1.47% 56 Current Accrued Expense is zł0.0 Mil as of Mar. 2026. GuruFocus rates WAR:IPE with a GF Score™ of 56/100 and a GF Value™ of zł3.63 (Significantly Overvalued). The stock has 8 warning signs investors should review.

IPOPEMA Securities's Current Accrued Expense for the quarter that ended in Mar. 2026 was zł0.0 Mil.

IPOPEMA Securities Current Accrued Expense Related Terms

IPOPEMA Securities Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for IPOPEMA Securities's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IPOPEMA Securities Current Accrued Expense Chart

IPOPEMA Securities Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IPOPEMA Securities Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:IPE
56GF Score
IPOPEMA Securities SA WAR:IPE
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IPOPEMA Securities Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of zł0.0 Mil mean?
IPOPEMA Securities (WAR:IPE) has a Current Accrued Expense of zł0.0 Mil as of Mar. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on IPOPEMA Securities and its competitors.
Is IPOPEMA Securities' Current Accrued Expense too high?
IPOPEMA Securities' current Current Accrued Expense is zł0.0 Mil. Overall, IPOPEMA Securities has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IPOPEMA Securities' Current Accrued Expense compare to MS and GS?
IPOPEMA Securities' Current Accrued Expense of zł0.0 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Capital Markets company?
A good Current Accrued Expense depends on the Capital Markets industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on IPOPEMA Securities and its competitors. IPOPEMA Securities's current Current Accrued Expense is zł0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IPOPEMA Securities stock overvalued right now?
Based on GuruFocus' analysis, IPOPEMA Securities (WAR:IPE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł3.63, compared to a current price of zł9.40 — trading 159% above its estimated fair value. The current Current Accrued Expense is zł0.0 Mil. IPOPEMA Securities' overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For IPOPEMA Securities (WAR:IPE), the current Current Accrued Expense is zł0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IPOPEMA Securities (WAR:IPE) Overvalued in 2026?

Based on GuruFocus' analysis, IPOPEMA Securities stock appears to be overvalued. The current stock price of zł9.40 is trading 159% above its estimated GF Value™ of zł3.63. GuruFocus considers IPOPEMA Securities to be Significantly Overvalued.

Key valuation signals for WAR:IPE:

  • Current Accrued Expense: zł0.0 Mil
  • GF Value™: zł3.63 vs. price of zł9.40 (159% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the WAR:IPE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IPOPEMA Securities Business Description

Address 9 Prozna Street, Warsaw, POL, 00-107
IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.
56GF Score

Get the complete analysis for WAR:IPE

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł9.40
Price
zł3.63
GF Value